XML 42 R31.htm IDEA: XBRL DOCUMENT
v3.25.1

Summary of Significant Accounting Policies (Details) - USD ($) $ in Thousands |  |  |  |  | 1 Months Ended | 3 Months Ended |
--- | --- | --- | --- | --- | --- | --- | ---
Jul. 22, 2024 | May 25, 2023 | Jul. 30, 2022 | Jun. 01, 2021 | May 31, 2021 | Mar. 31, 2025 | Mar. 31, 2024 | Dec. 31, 2024
Research and Development Arrangement, Contract to Perform for Others [Line Items] |  |  |  |  |  |  |  |
Deferred revenue |  |  |  |  |  | $ 680 |  | $ 555
Deferred revenue recognized |  |  |  |  |  | 200 | $ 600 |
Remaining performance obligation |  |  |  |  |  | 1,800 |  |
Grant period (in years) |  |  |  |  | 5 years |  |  |
Research and development arrangement with federal government, total budget |  |  |  |  | $ 9,300 |  |  |
Research and development arrangement with federal government, funding for subawards |  |  |  |  | $ 5,500 |  |  |
Approved funding, first year |  |  |  | $ 800 |  |  |  |
Approved funding for subawards, first year |  |  |  | $ 400 |  |  |  |
Approval for funding, year two |  |  | $ 2,600 |  |  |  |  |
Approval for funding, subawards, year two |  |  | $ 1,600 |  |  |  |  |
Approval for funding, year three |  | $ 3,000 |  |  |  |  |  |
Approval for funding subawards, year three |  | $ 1,500 |  |  |  |  |  |
Approval for funding, year four | $ 1,700 |  |  |  |  |  |  |
Approval for funding subawards, year four | $ 1,000 |  |  |  |  |  |  |
Funding received for costs incurred |  |  |  |  |  | 100 | $ 400 |
Prepaid expenses and other current assets |  |  |  |  |  | 2,201 |  | $ 2,352
Additional Funding Agreement Terms |  |  |  |  |  |  |  |
Research and Development Arrangement, Contract to Perform for Others [Line Items] |  |  |  |  |  |  |  |
Compensation earned |  |  |  |  |  | 3,900 |  |
Prepaid expenses and other current assets |  |  |  |  |  | 100 |  |
Variety of Health Care Organizations | UNITED STATES | Accounts Receivable | Customer Concentration Risk |  |  |  |  |  |  |  |
Research and Development Arrangement, Contract to Perform for Others [Line Items] |  |  |  |  |  |  |  |
Accounts receivable, with the exception of due |  |  |  |  |  | $ 100 |  |

X
- Definition Research and Development Arrangement with Federal Government, Approval for Funding Subawards, Year 2 + References No definition available. + Details
Name: | npce_ResearchAndDevelopmentArrangementWithFederalGovernmentApprovalForFundingSubawardsYear2
Namespace Prefix: | npce_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Research and Development Arrangement with Federal Government, Approval for Funding Subawards, Year 3 + References No definition available. + Details
Name: | npce_ResearchAndDevelopmentArrangementWithFederalGovernmentApprovalForFundingSubawardsYear3
Namespace Prefix: | npce_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Research and Development Arrangement with Federal Government, Approval for Funding Subawards, Year 4 + References No definition available. + Details
Name: | npce_ResearchAndDevelopmentArrangementWithFederalGovernmentApprovalForFundingSubawardsYear4
Namespace Prefix: | npce_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Research and Development Arrangement with Federal Government, Approval for Funding, Year 2 + References No definition available. + Details
Name: | npce_ResearchAndDevelopmentArrangementWithFederalGovernmentApprovalForFundingYear2
Namespace Prefix: | npce_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Research and Development Arrangement with Federal Government, Approval for Funding, Year 3 + References No definition available. + Details
Name: | npce_ResearchAndDevelopmentArrangementWithFederalGovernmentApprovalForFundingYear3
Namespace Prefix: | npce_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Research and Development Arrangement with Federal Government, Approval for Funding, Year 4 + References No definition available. + Details
Name: | npce_ResearchAndDevelopmentArrangementWithFederalGovernmentApprovalForFundingYear4
Namespace Prefix: | npce_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Research and Development Arrangement with Federal Government, Approved Funding Subawards, Year 1 + References No definition available. + Details
Name: | npce_ResearchAndDevelopmentArrangementWithFederalGovernmentApprovedFundingSubawardsYear1
Namespace Prefix: | npce_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Research and Development Arrangement with Federal Government, Approved Funding, Year 1 + References No definition available. + Details
Name: | npce_ResearchAndDevelopmentArrangementWithFederalGovernmentApprovedFundingYear1
Namespace Prefix: | npce_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Research and Development Arrangement with Federal Government, Estimated Cost for Subawards + References No definition available. + Details
Name: | npce_ResearchAndDevelopmentArrangementWithFederalGovernmentEstimatedCostForSubawards
Namespace Prefix: | npce_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Research and Development Arrangement with Federal Government, Term + References No definition available. + Details
Name: | npce_ResearchAndDevelopmentArrangementWithFederalGovernmentTerm
Namespace Prefix: | npce_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Research and Development Arrangement with Federal Government, Total Estimated Cost + References No definition available. + Details
Name: | npce_ResearchAndDevelopmentArrangementWithFederalGovernmentTotalEstimatedCost
Namespace Prefix: | npce_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(3)(a)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_AccountsReceivableGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2 + Details
Name: | us-gaap_ContractWithCustomerLiabilityCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8 + Details
Name: | us-gaap_ContractWithCustomerLiabilityRevenueRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 730 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1 + Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 730 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 730 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1 + Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of customer funding recorded as an offset to costs incurred for a fixed-price, best-efforts research and development cost-sharing arrangement with the Federal Government. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 912 -SubTopic 730 -Name Accounting Standards Codification -Section 25 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1 + Details
Name: | us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of transaction price allocated to performance obligation that has not been recognized as revenue. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -SubTopic 10 -Topic 606 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13 + Details
Name: | us-gaap_RevenueRemainingPerformanceObligation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_AdditionalFundingAgreementTermsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=npce_VarietyOfHealthCareOrganizationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |